Natalizumab in spinal relapsing-remitting multiple sclerosis

被引：0
|
作者：
Zecca, C. [1 ]
Kamm, C. [2 ]
Riccitelli, G. C. [1 ]
Heldner, M. [2 ]
Caporro, M. [1 ]
Gobbi, C. [1 ]
机构：
[1] Civ Hosp, Neuroctr Southern Switzerland, Lugano, Switzerland
[2] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland
来源：
JOURNAL OF NEUROLOGY | 2014年 / 261卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PP1229
引用
收藏
页码：S303 / S303
页数：1
相关论文
共 50 条
  • [1] Natalizumab in spinal relapsing-remitting multiple sclerosis
    Zecca, C.
    Kamm, C.
    Riccitelli, G. C.
    Heldner, M.
    Caporro, M.
    Gobbi, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 457 - 457
  • [2] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [3] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    [J]. NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [4] Predicting the response status to natalizumab in relapsing-remitting multiple sclerosis
    Prosperini, L.
    Mancinelli, C. R.
    Gianni, C.
    Barletta, V.
    Fubelli, F.
    Borriello, G.
    Pozzilli, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 469 - 470
  • [5] Natalizumab: A guide to its use in relapsing-remitting multiple sclerosis
    Keating G.M.
    McCormack P.L.
    [J]. Drugs & Therapy Perspectives, 2014, 30 (2) : 48 - 54
  • [6] Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis
    Rodriguez de Castro, Belen
    Martinez-Mugica Barbosa, Cristina
    Ayastuy Ruiz, Aitor
    Fernandez Gonzalez, Beatriz
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (02) : 112 - 114
  • [7] Natalizumab reduces apathy in relapsing-remitting multiple sclerosis patients
    Berkovich, R.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S154 - S155
  • [8] Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis
    Arnal-Garcia, Carmen
    Rosa Garcia-Montero, Ma
    Malaga, Ignacio
    Millan-Pascual, Jorge
    Oliva-Nacarino, Pedro
    Ramio-Torrenta, Lluis
    Oreja-Guevara, Celia
    [J]. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (01) : 50 - 54
  • [9] Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis
    Paul L. McCormack
    [J]. Drugs, 2013, 73 : 1463 - 1481
  • [10] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
    Cavit Boz
    Serkan Ozakbas
    Murat Terzi
    Rana Karabudak
    Serhan Sevim
    Recai Turkoglu
    Aysun Soysal
    Belgin Petek Balcı
    Hüsnü Efendi
    Ömer Faruk Turan
    Nur Yüceyar
    Mehmet Fatih Yetkin
    Serap Zengin Karahan
    Meltem Demirkıran
    Sibel Guler
    Kadriye Agan
    Nefati Kıylıoğlu
    Cavid Baba
    Asli Tuncer
    Mesrure Köseoğlu
    [J]. Neurological Sciences, 2023, 44 : 2121 - 2129
12345